39 related articles for article (PubMed ID: 28767177)
1. Intrinsically disordered regions regulate both catalytic and non-catalytic activities of the MutLα mismatch repair complex.
Kim Y; Furman CM; Manhart CM; Alani E; Finkelstein IJ
Nucleic Acids Res; 2019 Feb; 47(4):1823-1835. PubMed ID: 30541127
[TBL] [Abstract][Full Text] [Related]
2. All three mammalian MutL complexes are required for repeat expansion in a mouse cell model of the Fragile X-related disorders.
Miller CJ; Kim GY; Zhao X; Usdin K
PLoS Genet; 2020 Jun; 16(6):e1008902. PubMed ID: 32589669
[TBL] [Abstract][Full Text] [Related]
3. Punctate MLH1 mismatch repair immunostaining in colorectal cancer.
Loughrey MB; Dunne PD; Coleman HG; McQuaid S; James JA
Histopathology; 2019 Apr; 74(5):795-797. PubMed ID: 30379344
[No Abstract] [Full Text] [Related]
4. MutLα suppresses error-prone DNA mismatch repair and preferentially protects noncoding DNA from mutations.
Kadyrova LY; Mieczkowski PA; Kadyrov FA
J Biol Chem; 2024 May; 300(6):107406. PubMed ID: 38782208
[TBL] [Abstract][Full Text] [Related]
5. Mismatch repair protein MLH1 suppresses replicative stress in BRCA2-deficient breast tumors.
Sengodan SK; Hu X; Peddibhotla V; Balamurugan K; Mitrophanov AY; McKennett L; Kharat SS; Sanawar R; Singh VK; Albaugh ME; Burkett SS; Zhao Y; Tran B; Malys T; Sterneck E; De S; Sharan SK
J Clin Invest; 2024 Jan; 134(7):. PubMed ID: 38271119
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Catalytic Lysine Residue Conserved Among GHKL ATPases: MutL, GyrB, and MORC.
Fukui K; Fujii Y; Yano T
J Mol Biol; 2024 May; 436(10):168575. PubMed ID: 38641238
[TBL] [Abstract][Full Text] [Related]
7. All three MutL complexes are required for repeat expansion in a human stem cell model of CAG-repeat expansion mediated glutaminase deficiency.
Hayward B; Kumari D; Santra S; van Karnebeek CDM; van Kuilenburg ABP; Usdin K
Sci Rep; 2024 Jun; 14(1):13772. PubMed ID: 38877099
[TBL] [Abstract][Full Text] [Related]
8. MutLα suppresses error-prone DNA mismatch repair and preferentially protects noncoding DNA from mutations.
Kadyrova LY; Mieczkowski PA; Kadyrov FA
bioRxiv; 2024 Apr; ():. PubMed ID: 38617288
[TBL] [Abstract][Full Text] [Related]
9. Identification PMS1 and PMS2 as potential meiotic substrates of CDK2 activity.
Palmer N; Talib SZA; Goh CMF; Biswas K; Sharan SK; Kaldis P
PLoS One; 2023; 18(3):e0283590. PubMed ID: 36952545
[TBL] [Abstract][Full Text] [Related]
10. Lynch syndrome, molecular mechanisms and variant classification.
Abildgaard AB; Nielsen SV; Bernstein I; Stein A; Lindorff-Larsen K; Hartmann-Petersen R
Br J Cancer; 2023 Mar; 128(5):726-734. PubMed ID: 36434153
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation.
Daniels HG; Knicely BG; Miller AK; Thompson A; Plattner R; Goellner EM
Front Genet; 2022; 13():940073. PubMed ID: 36338985
[TBL] [Abstract][Full Text] [Related]
12. PMS2 variant results in loss of ATPase activity without compromising mismatch repair.
D'Arcy BM; Arrington J; Weisman J; McClellan SB; Vandana ; Yang Z; Deivanayagam C; Blount J; Prakash A
Mol Genet Genomic Med; 2022 Feb; 10(5):e1908. PubMed ID: 35189042
[TBL] [Abstract][Full Text] [Related]
13. Narrative review of emerging roles for AKT-mTOR signaling in cancer radioimmunotherapy.
Shen C; He Y; Chen Q; Feng H; Williams TM; Lu Y; He Z
Ann Transl Med; 2021 Oct; 9(20):1596. PubMed ID: 34790802
[TBL] [Abstract][Full Text] [Related]
14. A Novel Germline
Klančar G; Blatnik A; Šetrajčič Dragoš V; Vogrič V; Stegel V; Blatnik O; Drev P; Gazič B; Krajc M; Novaković S
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32197529
[TBL] [Abstract][Full Text] [Related]
15. Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome.
Abildgaard AB; Stein A; Nielsen SV; Schultz-Knudsen K; Papaleo E; Shrikhande A; Hoffmann ER; Bernstein I; Gerdes AM; Takahashi M; Ishioka C; Lindorff-Larsen K; Hartmann-Petersen R
Elife; 2019 Nov; 8():. PubMed ID: 31697235
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and structural characterization of two variants of uncertain significance in the PMS2 gene.
D'Arcy BM; Blount J; Prakash A
Hum Mutat; 2019 Apr; 40(4):458-471. PubMed ID: 30653781
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2.
Hinrichsen I; Weßbecher IM; Huhn M; Passmann S; Zeuzem S; Plotz G; Biondi RM; Brieger A
Mol Carcinog; 2017 Dec; 56(12):2663-2668. PubMed ID: 28767177
[TBL] [Abstract][Full Text] [Related]
18. DNA mismatch repair activity of MutLα is regulated by CK2-dependent phosphorylation of MLH1 (S477).
Weßbecher IM; Hinrichsen I; Funke S; Oellerich T; Plotz G; Zeuzem S; Grus FH; Biondi RM; Brieger A
Mol Carcinog; 2018 Dec; 57(12):1723-1734. PubMed ID: 30136313
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
